Biological Basis of Differential Susceptibility to Hepatocarcinogenesis among Mouse Strains
Open Access
- 1 January 2009
- journal article
- Published by Japanese Society of Toxicologic Pathology in Journal of Toxicologic Pathology
- Vol. 22 (1), 11-33
- https://doi.org/10.1293/tox.22.11
Abstract
There is a vast amount of literature related to mouse liver tumorigenesis generated over the past 60 years, not all of which has been captured here. The studies reported in this literature have generally been state of the art at the time they were carried out. A PubMed search on the topic “mouse liver tumors” covering the past 10 years yields over 7000 scientific papers. This review address several important topics related to the unresolved controversy regarding the relevance of mouse liver tumor responses observed in cancer bioassays. The inherent mouse strain differential sensitivities to hepatocarcinogenesis largely parallel the strain susceptibility to chemically induced liver neoplasia. The effects of phenobarbital and halogenated hydrocarbons in mouse hepatocarcinogenesis have been summarized because of recurring interest and numerous publications on these topics. No single simple paradigm fully explains differential mouse strain responses, which can vary more than 50-fold among inbred strains. In addition to inherent genetics, modifying factors including cell cycle balance, enzyme induction, DNA methylation, oncogenes and suppressor genes, diet, and intercellular communication influence susceptibility to spontaneous and induced mouse hepatocarcinogenesis. Comments are offered on the evaluation, interpretation, and relevance of mouse liver tumor responses in the context of cancer bioassays.Keywords
This publication has 156 references indexed in Scilit:
- A sequence-based variation map of 8.27 million SNPs in inbred mouse strainsNature, 2007
- NTP Workshop: Animal Models for the NTP Rodent Cancer Bioassay: Stocks and Strains—Should We Switch?Toxicologic Pathology, 2006
- Monograph: Reassessment of human cancer risk of aldrin/dieldrinToxicology Letters, 1999
- Genomic Imprinting and CancerExperimental Cell Research, 1999
- Alterations in the methylation status and expression of theraf oncogene in phenobarbital-induced and spontaneous B6C3F1 mouse liver tumorsMolecular Carcinogenesis, 1994
- Effect of the age of B6C3F1 mice on phenobarbital promotion of diethylnitrosamine-initiated liver tumorsToxicology and Applied Pharmacology, 1987
- Carcinogenicity of chlorinated methane and ethane compounds administered in drinking water to mice.Environmental Health Perspectives, 1986
- Inhibition by phenobarbital and lack of effect of amobarbital on the development of liver tumors induced by N-nitrosodiethylamine in juvenile B6C3F1 miceCancer Letters, 1984
- Complete regression of hepatocellular adenoma after withdrawal of oral contraceptivesDigestive Diseases and Sciences, 1981
- The mouse liver tumor as an endpoint in carcinogenesis testsToxicology and Applied Pharmacology, 1979